Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,543 | 40,444 | 114,053 | 95,865 | 70,834 |
| Receivables | 3,031 | 2,133 | 3,149 | 43,914 | 56,424 |
| Inventories | 784 | 838 | 1,831 | 21,305 | 24,383 |
| Other current assets | 0 | 3,063 | 41,529 | 0 | 0 |
| TOTAL | $56,975 | $59,379 | $173,154 | $172,630 | $172,364 |
| Non-Current Assets | |||||
| PPE Net | 1,276 | 866 | 2,391 | 30,238 | 31,263 |
| Intangibles | 69,747 | 83,057 | 90,937 | 254,841 | 591,245 |
| Other Non-Current Assets | 512 | 1,368 | 104,467 | 5,546 | 752 |
| TOTAL | $71,535 | $85,291 | $197,795 | $290,625 | $623,260 |
| Total Assets | $128,510 | $144,670 | $370,949 | $463,255 | $795,624 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,432 | 2,409 | N/A | N/A | 1,774 |
| Accounts payable and accrued liabilities | 2,407 | 3,777 | 3,128 | 8,495 | 24,871 |
| Accrued Expenses | 15,395 | 13,077 | 16,951 | 65,253 | 87,237 |
| Other current liabilities | N/A | N/A | 34,484 | N/A | N/A |
| TOTAL | $19,723 | $20,108 | $55,784 | $75,937 | $114,001 |
| Non-Current Liabilities | |||||
| Long Term Debt | 55,500 | 43,800 | 219,525 | 267,950 | 266,803 |
| Other Non-Current Liabilities | 2,115 | 3,878 | 1,439 | 3,116 | 2,541 |
| TOTAL | $57,694 | $47,829 | $221,309 | $272,610 | $297,776 |
| Total Liabilities | $77,417 | $67,937 | $277,093 | $348,547 | $411,777 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 99,350 | 83,515 | 62,719 | 58,899 | 52,519 |
| Common Shares | 992 | 833 | 625 | 518 | 525 |
| Retained earnings | -569,222 | -517,530 | -452,610 | -373,021 | -102,120 |
| Other shareholders' equity | 0 | 1,700 | -2,229 | -2,229 | -1,846 |
| TOTAL | $51,093 | $76,733 | $93,856 | $114,708 | $383,847 |
| Total Liabilities And Equity | $128,510 | $144,670 | $370,949 | $463,255 | $795,624 |